DK2139453T3 - Topisk polyaphronsammensætning med vitamin D - Google Patents

Topisk polyaphronsammensætning med vitamin D

Info

Publication number
DK2139453T3
DK2139453T3 DK08718742.3T DK08718742T DK2139453T3 DK 2139453 T3 DK2139453 T3 DK 2139453T3 DK 08718742 T DK08718742 T DK 08718742T DK 2139453 T3 DK2139453 T3 DK 2139453T3
Authority
DK
Denmark
Prior art keywords
vitamin
composition
topical
polyaphrone
analogue
Prior art date
Application number
DK08718742.3T
Other languages
English (en)
Inventor
Derek Alfred Wheeler
David Fraser Steele
Original Assignee
Drug Delivery Solutions Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Delivery Solutions Ltd filed Critical Drug Delivery Solutions Ltd
Application granted granted Critical
Publication of DK2139453T3 publication Critical patent/DK2139453T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK08718742.3T 2007-03-15 2008-03-14 Topisk polyaphronsammensætning med vitamin D DK2139453T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07251084A EP1970048A1 (en) 2007-03-15 2007-03-15 Polyaphron topical composition with vitamin D
PCT/GB2008/000900 WO2008110819A1 (en) 2007-03-15 2008-03-14 Polyaphron topical composition with vitamin d

Publications (1)

Publication Number Publication Date
DK2139453T3 true DK2139453T3 (da) 2011-08-15

Family

ID=38294028

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08718742.3T DK2139453T3 (da) 2007-03-15 2008-03-14 Topisk polyaphronsammensætning med vitamin D

Country Status (7)

Country Link
US (1) US20100093676A1 (da)
EP (2) EP1970048A1 (da)
AT (1) ATE507819T1 (da)
DE (1) DE602008006710D1 (da)
DK (1) DK2139453T3 (da)
ES (1) ES2364883T3 (da)
WO (1) WO2008110819A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
WO2006129161A2 (en) 2005-06-01 2006-12-07 Stiefel Research Australia Pty Ltd Vitamin formulation
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US9610245B2 (en) * 2011-03-14 2017-04-04 Drug Delivery Solutions Limited Ophthalmic composition
RU2758335C2 (ru) * 2015-02-02 2021-10-28 Сантен Фармасьютикал Ко., Лтд Композиция, способ трансдермальной доставки полиафрона, способ контролируемого высвобождения ингредиента
GB201701583D0 (en) * 2017-01-31 2017-03-15 Drug Delivery Solutions Ltd Topical composition
CN108663441B (zh) * 2017-12-30 2021-03-30 南京海融制药有限公司 一种他卡西醇软膏剂有关物质检查方法
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486333A (en) * 1981-04-10 1984-12-04 Felix Sebba Preparation of biliquid foam compositions
GB9300763D0 (en) * 1993-01-15 1993-03-03 Leo Pharm Prod Ltd Chemical compound
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
US6238678B1 (en) * 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
ES2177936T3 (es) * 1996-03-08 2002-12-16 Disperse Ltd Dispersion estable consistente en una espuma biliquida basada en aceite y un gel acuoso.
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PL199123B1 (pl) * 1999-04-23 2008-08-29 Leo Pharm Prod Ltd Niewodna kompozycja farmaceutyczna do stosowania naskórnego i jej zastosowanie
BRPI0114927B8 (pt) * 2000-10-27 2021-05-25 Leo Pharma As composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição
WO2005001643A2 (en) * 2003-06-21 2005-01-06 J Maev Jack Ivan Method and apparatus for encouraged visitation web advertising
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
GB0317868D0 (en) * 2003-07-30 2003-09-03 Disperse Ltd Biliquid foams with a high alcohol content and products formulated therefrom
FR2862540B1 (fr) * 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
GB0404403D0 (en) * 2004-02-27 2004-03-31 Disperse Ltd Dispersions
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie

Also Published As

Publication number Publication date
DE602008006710D1 (de) 2011-06-16
US20100093676A1 (en) 2010-04-15
WO2008110819A1 (en) 2008-09-18
ATE507819T1 (de) 2011-05-15
ES2364883T3 (es) 2011-09-16
EP2139453A1 (en) 2010-01-06
EP2139453B1 (en) 2011-05-04
EP1970048A1 (en) 2008-09-17

Similar Documents

Publication Publication Date Title
DK2139453T3 (da) Topisk polyaphronsammensætning med vitamin D
BRPI0811718A2 (pt) Derivados de 3,3-espiroindolinona
HUE041959T2 (hu) Kannabinoid-tartalmú extraktumok, mint neuroprotektív ágensek
BRPI0808163A2 (pt) Composição para aplicação tópica, métodos para tratar uma condição de superfície em um indivíduo, para preparar uma composição, e para usar o kit, e, kit
DE602008005634D1 (de) 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivate
BRPI0816970A2 (pt) 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
EP2347147A4 (en) ROTATING ASSEMBLIES, ROTATING MECHANISMS AND ASSOCIATED APPLICATIONS
HRP20151058T1 (xx) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
NL2000527A1 (nl) Dibenzylamine-verbindingen en -derivaten.
NL2003100A1 (nl) Track system with adjustable width.
BRPI0916363A2 (pt) derivados de 4,5-di-hidro-oxazol-2-ila
DE602007001681D1 (de) 1,3-dioxan-carboxylsäuren
BRPI0920347A2 (pt) dispositivo de segurança com pelo menos uma marcação táctil durável.
BRPI0815755A2 (pt) Mancal liso reforçado por metal.
NL1031627A1 (nl) Acylaminobicyclische heteroaromatische verbindingen en toepassingen daarvan.
FR2923713B1 (fr) Composition reductrice epaissie.
NL2000514A1 (nl) Dibenzylamine-verbindingen en -derivaten.
DE502006009397D1 (de) Emulgatorzusammensetzung auf basis von pentaerythrren
BRPI0909356A2 (pt) Composição ectoparasitica tópica, uso de uma composição, e, kit.
DE602006012102D1 (de) Ventilklappen mit gleitenden Mitglied
BRPI0807880A2 (pt) Composição anestésica em spray.
ATE502918T1 (de) Arylsulfonamide mit analgetischer wirkung
ATE519751T1 (de) Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate
BRPI0809933A2 (pt) Bola.